Objectives: Tie2 is a tyrosine kinase receptor expressed by endothelial cells that maintains vascular barrier function. We recently reported that diverse critical illnesses acutely decrease Tie2 expression and that experimental Tie2 reduction suffices to recapitulate cardinal features of the septic vasculature. Here we investigated molecular mechanisms driving Tie2 suppression in settings of critical illness. Design: Laboratory and animal research, postmortem kidney biopsies from acute kidney injury patients and serum from septic shock patients.
P athologic host responses to infection drive the syndrome of sepsis (1) . Mortality in its most severe form-septic shockcan exceed 60%, and its occurrence rate is rising (2) . So far, specific therapeutic strategies that target the host response have focused on the modulation of the immune response (e.g., tumor necrosis factor [TNF]-α inhibition [3] ). However, the individual immune status of a given patient is highly variable, can change quickly, and so far, no reliable monitoring tools are available. In response to pathogen products and early-response cytokines, the microvasculature undergoes a dramatic transformation during sepsis (4) .. The septic host vascular response is characterized by a proadhesive, proapoptotic, proinflammatory endothelial surface and increased permeability (5) (6) (7) . These changes collaborate to reduce tissue perfusion and oxygenation, thereby contributing to multiple organ dysfunction and death.
The Tie2 tyrosine kinase has been increasingly recognized as a molecular switch that shifts the endothelium from quiescence to promote the vascular phenotypes of sepsis (8) . Reports from many laboratories now show that numerous manipulations of Tie2's endogenous ligands-the angiopoietins-that favor receptor activation lead to improvement of survival and organ function in rodent sepsis (9) (10) (11) (12) . Comparatively less attention has focused on regulation of the receptor itself, whose expression is markedly reduced in sepsis (14) (15) (16) . We recently showed that diverse severe infections share a common reduction of Tie2 expression, and that loss of Tie2 even in the absence of infection is sufficient to destabilize the vasculature (13) . Together, these studies implicate a model in which sustained or increased Tie2 signaling may combat adverse outcomes in sepsis, whereas the pathogenic host response of sepsis may be intimately linked to Tie2 suppression.
In this study, we sought to understand mechanisms by which diverse severe infections could converge on the suppression of Tie2. We therefore focused on board pathophysiologic processes common to such settings, namely severe inflammation and reduced flow. We found that inflammation drives a protein-level, that is, posttranslational, suppression of Tie2 and that reduced flow suppresses Tie2 transcripts.
MATERIAL AND METHODS

Antibodies and Reagents
All chemicals and reagents were purchased from SigmaAldrich (St. Louis, MO) unless otherwise specified. Antibodies against Tie2 (C-20) (Santa Cruz Biotechnology, Dallas, TX), Tie2 (clone Ab33) (Merck Millipore, Darmstadt, Germany), GATA binding protein 3 (GATA3) (D13C9) (Cell Signaling Technology, Danvers, MA), matrix metalloproteases (MMP) 14/membrane type 1-MMP (D1E4) (Cell Signaling Technology), phospho AKT (Ser473, D9E) (Cell Signaling Technology), AKT (11E7) (Cell Signaling), and ubiquitin (Cell Signaling Technology), β-tubulin, and glyceraldehyde 3-phosphate dehydrogenase (Santa Cruz Biotechnology) were used. Soluble Tie2 levels were determined using the human Tie-2 DuoSet enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN) and the mouse Tie-2 Quantikine Kit (R&D Systems). Human umbilical vein endothelial cells (HUVECs) were stimulated with TNF-α, angiopoietin-1, and angiopoietin-2 (all from R&D Systems). 
Clinical Observational Trial
Mouse Studies and Experimental Design
All experiments were approved by the local authorities and conducted in accordance with institutional and governmental guidelines. Eight-week-old male C57Bl/6 mice were purchased from Charles River Laboratories (Sulzfeld, Germany). Sepsis was induced via cecal ligation and puncture (CLP) as described before (18, 19) . Sham mice underwent the same procedure except for ligation and puncture. For induction of endotoxemia, mice received 17.5 mg/kg body weight lipopolysaccharide intraperitoneally from Escherichia coli (serotype O111:B4) or vehicle. Endothelial cells (ECs) were isolated from murine lungs using a dissociation kit (MACS Miltenyi, Bergisch Gladbach, Germany) and CD146 microbeads together with the MACS magnetic separation system. The purity was 91.3% ± 0.7%.
In Vitro Cell Culture Studies
HUVECs (passage 3-5) were cultured in endothelial growth medium-2 medium (Lonza, Basel, Switzerland). For stimulation experiments, HUVECs were starved overnight (0.5% fetal bovine serum, without supplements) and stimulated with TNF-α. Transfection of HUVECs with siRNA was accomplished using Silencer siRNAs (Thermo Fisher Scientific, Waltham, MA). For flow experiments, 1.2 × 10 5 HUVECs were seeded on 0.4 luer slides (Ibidi, Martinsried, Germany). After 24 hours, cells were put under flow (20 dynes/cm 2 ) for indicated times using a fluidic unit and pump system from Ibidi.
Real-Time Quantitative Polymerase Chain Reaction
Total RNA was extracted using the RNeasy Mini/Micro Kit (Qiagen, Hilden, Germany) and then reverse transcribed using Transcriptor First Strand complementary DNA Synthesis (Roche Diagnostics, Risch-Rotkreuz, Switzerland). Real-time quantitative polymerase chain reaction (RT-qPCR) was performed by a LightCycler 480 II (Roche Diagnostics). Triplicate RT-qPCR analyses were performed for each sample. Gene expression was normalized to the expression of the housekeeping gene, yielding the ∆CT value.
Immunoblotting
Protein was extracted by using radioimmunoprecipitation assay buffer, resolved with a 10% polyacrylamide gel, followed by blotting on a polyvinylidene fluoride membrane (Merck Millipore), blocked with 3% bovine serum albumin and incubated with a primary antibody overnight (4°C). Incubation with the second antibody was performed for 1 hour at room temperature. Bands were visualized with SuperSignal West Pico chemiluminescent Substrate (Life Technologies, Carlsbad, CA) and Versa Doc Imaging System Modell 3000 (BioRad, Hercules, CA).
Quantification of immunoblots was accomplished using Quantity One 4.6.6 (BioRad).
GATA3 Plasmid Transfection and Cell Sorting
HUVECs were transfected with a GATA3 overexpressing (GATA3 pEZ-M61) or control plasmid (hLuc pReceiver-M61) using Xtreme Gene HP reagent (Roche Diagnostics) 3 hours after seeding to 70% confluency. Both plasmids express green fluorescent protein under the same promoter to mark transfected cells. After 48 hours, sorting of GFP+ cells was accomplished with a FACS Calibur (BD Biosciences, Franklin Lakes, NJ) for further analysis.
Transendothelial Electrical Resistance
Transendothelial electrical resistance (TER) was measured using an electric cell-substrate impedance sensing system (Applied BioPhysics, Troy, NY) (20) . Values were pooled at discrete time points and plotted versus time. Each condition's endpoint resistance was divided by its starting resistance to give the normalized TER.
Human Kidney Biopsies
We reevaluated postmortem kidney biopsies (21) from 16 patients 18 years old or older, who died of sepsis. Patients with preexisting chronic kidney disease, active autoimmune disorder with renal involvement, and immune-suppressive treatment were excluded. Normal parts of kidneys from 12 patients who underwent a total nephrectomy for renal tumors served as controls. Families were given oral and written information about the postmortem study. The postmortem biopsies were waived by the Medical Ethical Committee of the University Medical Center Groningen, Groningen, The Netherlands (METc 2011/372).
Statistical Analysis
Statistical significance was evaluated using Mann-Whitney U test unless otherwise noted. For correlation statistics, Spearman test was performed. All experimental results are presented as mean ± sem, and two-tailed p value of less than 0.05 was considered to indicate statistical significance. Analysis and graph generation were performed in GraphPad Prism 6.0 (GraphPad Software, Inc.; La Jolla, CA).
RESULTS
Acute Down-Regulation of Tie2 In Vivo and In Vitro
Applying the CLP surgical model in mice, we confirmed that sepsis profoundly lowers Tie2 expression both at the level of protein and messenger RNA (mRNA) (Supplemental Fig. 1 , A-C, Supplemental Digital Content 1, http://links.lww.com/ CCM/D689). In order to elucidate the underlying mechanisms, we focused on two central pathophysiologic responses associated with sepsis: inflammation and reduced flow. Testing different inflammatory mediators of sepsis (interferon-γ, interleukin1-β, lipopolysaccharide, and TNF-α) to ECs, we found TNF-α was a potent and sustained suppressor of Tie2 protein. In contrast, the transcriptional response to TNF-α was biphasic with an early drop in Tie2 mRNA followed by an increase up to two-fold after 24 hours. TNF-α was also able to replicate functional endothelial consequences of sepsis (Supplemental Fig. 1 , D-G, Supplemental Digital Content 1, http:// links.lww.com/CCM/D689). The discrepancy between protein and mRNA response suggested that TNF-α may be provoking a distinct effect on Tie2 protein unrelated to previously described transcriptional regulation (22) .
Regulation of Tie2 Protein by Posttranslational Ectodomain Shedding
To evaluate TNF-α-dependent posttranslational Tie2 regulation, we first sought to establish an effect on protein distinct from an effect on mRNA. We therefore compared Tie2 mRNA stability to protein expression. The in vitro half-life of Tie2 mRNA appears to be approximately 10 hours (Supplemental Notably, we found no effect of ligand-driven Tie2 stimulation (Supplemental Using an ELISA technique to detect the extracellular N-terminal epitope of Tie2, we found that TNF-α indeed increased the sTie2 in HUVEC supernatants ( Fig. 1A;  Supplemental Fig. 6 , Supplemental Digital Content 1, http:// links.lww.com/CCM/D689). Consistent with this in vitro finding, we also observed an increase of the soluble N-terminal extracellular sTie2 fragment in the serum of septic C57/Bl6 mice (Fig. 1A) . We then measured the circulating sTie2 fragment in sera from 57 septic shock patients and 22 healthy controls (demographics summarized in Supplemental Table 1 , Supplemental Digital Content 2, http://links.lww.com/CCM/D690). Septic humans had significantly higher sTie2 levels compared with healthy controls (control:
12.29 ± 0.71 ng/mL vs septic humans: 18.77 ± 0.48 ng/mL; p < 0.0001) (Fig. 1A) . Furthermore, levels of sTie2 were associated with circulating C-reactive protein, a marker of systemic inflammation (r = 0.3; p = 0.008), with the Tie2 antagonist angiopoietin-2 (r = 0.4; p = 0.0025) and with the complement factor C3 (r = 0.3; p = 0.009) (Supplemental Fig. 7 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689). Together, these data suggested that inflamed ECs, septic mice, and septic humans may share a common mechanism of Tie2 shedding.
Mechanistic Role of MMP14 in Septic Tie2 Shedding
During angiogenesis, Tie2 is proteolytically cleaved by the MMP14 to generate a soluble ectodomain fragment (22) . MMP14 was increased in septic murine lungs ( Fig. 1B; Supplemental Fig.  8 , Supplemental Digital Content 1, http://links.lww.com/CCM/ D689), proposing a putative mechanism. We therefore conducted RNA interference (RNAi) against MMP14 in TNF-α-stimulated HUVECs (Supplemental Fig. 9 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689). This manoeuvre abrogated the TNF-α-driven appearance of sTie2 ( Fig. 2A) in EC supernatants. The same dependence on MMP14 was evident when lipopolysaccharide was applied to ECs (Supplemental Fig. 10 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689). A pharmacologic blockade of MMPs with a compound termed "GM6001" (Supplemental Fig. 11 , Supplemental Digital Content 1, http:// links.lww.com/CCM/D689) not only affected TNF-α-driven shedding but also strongly inhibited baseline Tie2 shedding ( Fig.  2A, comparison bar 1 and 3) . Next, we added human (recombinant human) MMP14 to resting ECs to confirm that MMP14 was sufficient to cleave Tie2 (p < 0.01) (Fig. 2B) .
To investigate the signaling consequences of Tie2 proteolytic cleavage, we measured phosphorylation of AKT, a canonical kinase downstream of Tie2. Knockdown of MMP14 enhanced both basal and ligand-induced AKT phosphorylation in HUVECs (Fig. 2C, and soluble ectodomain fraction of Tie2 (sTie2) were quantified in supernatants by enzyme-linked immunosorbent assay (ELISA) (n = 6, **p < 0.01). B, sTie2 ELISA of supernatants from HUVECs stimulated with vehicle, 10 µmol/L GM6001 (a global MMP blocker as positive control) or recombinant human (rh) MMP14 at three different doses (low, 40 µg/mL; medium, 100 µg/mL; and high, 300 µg/mL) (n = 6, **p < 0.01, ***p < 0.001). C, Tie2 downstream signaling in control or MMP14 siRNA transfected HUVECs has been evaluated by immunoblot for phospho AKT (pAKT), AKT, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) after stimulation with 500 ng/ mL angiopoietin (Angpt)-1 for 10 min. Bar graphs show densitometric quantification of the above results for pAKT over AKT (n = 7, **p < 0.01, ***p < 0.001). Exemplary immunoblot can be found in Supplemental Figure 
Transcriptional Tie2 Regulation in Sepsis Is Flow Responsive
The above data demonstrated that MMP14 induction is necessary and sufficient for Tie2 proteolytic cleavage during inflammation but did not explain why sepsis yields a sustained reduction in Tie2 transcripts. Based on an earlier observation from our group showing flow dependency of Tie2 transcription (13) and on the fact that reduced perfusion of the microvasculature is a common shared phenomenon in different critical illnesses that all lead to Tie2 suppression (14), we further analyzed flow-responsive genes in this context. First, we confirmed that Tie2 mRNA was indeed flow regulated in ECs. Under no flow condition, Tie2 mRNA was modestly, but significantly, reduced when compared with a 20 dyne/cm 2 flow. To further analyze the loss of mRNA, we screened for flow responsiveness of several transcription factors that have been linked to Tie2 in previous reports (4) . Among others (Supplemental Fig. 13 , Supplemental Digital Content 1, http://links. lww.com/CCM/D689), we found that the transcription factors GATA3 and Krüppel-like factor (KLF) 2 were most responsive to flow ( F ig. 3A). However, only GATA3 reduction (Fig. 3B , black bars), but not KLF2 reduction (white bars), was sufficient to reduce Tie2 transcript levels. Furthermore, knockdown of GATA3 reduced both basal barrier function and angiopoietin-1 induced barrier strengthening (Fig. 3C) , revealing the functional impact of GATA3 on the angiopoietin-Tie2 pathway.
The reverse approach (i.e., overexpression) was applied to test if GATA3 was sufficient to induce Tie2 transcription in the absence of flow. Using a GFP-tagged GATA3 plasmid and sorting for GFP+ cells, we observed an immense increase in GATA3 mRNA (10.000-fold) but no significant change in Tie2 (Supplemental Fig. 14 , Supplemental Digital Content 1, http:// links.lww.com/CCM/D689).
In comparison to the several other transcription factors previously linked to Tie2, only GATA3 expression was suppressed by sepsis (Fig. 4A, black bars; Supplemental Fig. 15 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689). Because GATA3 is also expressed by non-ECs, we isolated CD146 + ECs from septic and control murine lungs to confirm that sepsis suppresses endothelial GATA3 in vivo (Fig. 4A, white bars) .
Returning to the concept of shear stress that led us to explore GATA3 among a larger set of flow-responsive genes, we tested whether flow-dependent induction of Tie2 expression requires GATA3. ECs in which GATA3 had been silenced by siRNA (Supplemental Fig. 16 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689) were markedly impaired in the Tie2 transcriptional response to flow compared with nonsilenced ECs exposed to the same flow ( Fig. 4B; Supplemental  Fig. 17 , Supplemental Digital Content 1, http://links.lww.com/ CCM/D689).
Further, we tested whether there was a graded association between the degree of GATA3 expression and the degree of Tie2 expression in several model systems: 1) whole lung homogenates from lipopolysaccharide-challenged mice; 2) whole lung homogenates from CLP mice; 3) isolated pulmonary ECs from lipopolysaccharide-challenged mice; and 4) in vitro from ECs under flow and static conditions. In all four of these settings, we found a highly significant correlation between Tie2 and GATA3 expression (Supplemental Fig. 18 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689).
GATA3 Is Associated With Tie2 Expression in Human Septic Kidneys
Despite a large body of evidence implicating imbalanced circulating Tie2 ligands in septic humans (8) , data on tissue expression or even the activation status of Tie2 in septic humans have been challenging to obtain. Recently, changes in renal Tie2 mRNA expression were reported in human sepsis (23) . Given the present findings, we tested whether the association between GATA3 and Tie2 expression observed in septic mice is reproducible in human samples. To do this, we analyzed kidney biopsies from deceased septic patients for GATA3 mRNA expression. We observed a trend for reduced GATA3 expression among the septic tissues (Fig. 5A) . When we conducted the continuous comparison against Tie2 expression, we observed an intercorrelation that was statistically significant (Fig. 5B) . This result not only validated our findings in cultured ECs and septic mice, but also suggested that GATA3-dependent regulation of Tie2 may be a cell-autonomous mechanism of vascular inflammation conserved across species.
DISCUSSION
Tie2 actively promotes vascular homeostasis during quiescence, and in the setting of sepsis, phosphorylation of Tie2 counteracts the development of a proadhesive, procoagulant, and leaky phenotype (11, 24) . Although the imbalance in Tie2 ligands that develops during sepsis has been appreciated for over a decade (25) , only recently has attention focused on the regulation of Tie2 expression itself during sepsis and related kinds of severe illness (14) . Shared across these settings, reduced Tie2 expression has been shown to suffice to trigger vascular leakage and to enhance coagulation in vivo even in the absence of infection or inflammation. As such, reduction in Tie2 expression during critical illnesses may be a sentinel event in the switch from vascular quiescence to activation. By focusing on twin fundamental pathophysiologic disturbances in sepsis-inflammation and reduced microvascular flowthe present results identified two distinct mechanisms by which Tie2 expression is down-regulated during sepsis, advancing the field toward a more complete understanding of the host vascular response to severe infection.
We first identified a protein-level down-regulation of Tie2 that was uncoupled from the Tie2 mRNA response to canonical inflammatory mediators. After ruling out ubiquitin-mediated Tie2 degradation and ligation-dependent receptor internalization, we focused on proteolytic cleavage that results in shedding of Tie2's extracellular ligand-binding domain and degradation of its membrane-associated endodomain. We found that MMP14 was both necessary and sufficient for Tie2 cleavage and that MMP14 status impacted both the basal and ligand-induced barrier function of confluent endothelium. These results strongly propose endothelial MMP14 as a key molecular and functional regulator of vascular quiescence during sepsis. Based on these findings, endothelial MMP14 may well be a promising target for clinical inhibition.
To understand the sustained reduction in Tie2 mRNA reported in vivo, we hypothesized a role for laminar flow and shear stress, which are largely lost at the apical surface of microvascular endothelium as sepsis evolves into shock. Analyzing a set of previously reported flow-responsive genes (26-28), we found that flow enhances Tie2 mRNA expression in a GATA3-dependent fashion. Targeted depletion of GATA3 reduced flow-dependent Tie2 induction. Furthermore, we observed a quantitative relationship between GATA3 and Tie2 mRNA in septic mice, suggesting that gradations of flow impairment may "tune" the host vascular response across a spectrum of phenotypic severity. Integrating these results, we propose that Tie2 expression during sepsis is down-regulated at a minimum of two different levels, which together, may synergize to rapidly switch the endothelium from quiescence to activation in response to severe infection (Supplemental Fig. 19 , Supplemental Digital Content 1, http://links.lww.com/CCM/D689).
The present results advance our fundamental understanding of Tie2 regulation in several ways. Proteolytic cleavage of cell surface receptors is a widely recognized mechanism for modulating signal transduction (29, 30) . Tie2 ectodomain shedding has been reported in nonseptic classical vascular pathologies such as atherosclerosis (31) (32) (33) , and a link to MMP14 has also been proposed (34) . Our results extend this body of work into sepsis, where our data suggest that MMP14 inhibition may enhance both basal barrier function and Tie2-dependent barrier strengthening. These results suggest that Tie2 cleavage by MMP14 is pathogenic in the context of sepsis. However, one study showed that MMP14 −/− mice have increased vascular leakage (35) . Several possibilities could explain the contrast with our results: 1) developmental effects on MMP14 knockout; 2) MMP14 action in non-ECs; and 3) MMP14 action in ECs, but not on Tie2. For example, the orphan receptor Tie1 is itself rapidly cleaved during acute inflammation (36) . Future studies could focus on conditional, endothelial-specific MMP14 disruption. With promising results in such a genetic model subjected to sepsis, therapeutic endothelial MMP14 inhibition-for example, by encapsulated RNAi (37)-could be developed for sepsis. Simultaneously, proteomic efforts could be undertaken to identify the set of endothelial targets for MMP14. TNF-α surely can induce endothelial permeability and inflammation by a variety of additional mechanisms independent from Tie2 shedding. Finally, although the cleavage studies point to endothelial MMP14 as a compelling target for future study, the mechanisms by which TNF-α induces vascular hyperpermeability are likely to be manifold in vivo (38) .
Whereas the proteolytic cleavage of Tie2 may facilitate a rapid initial response, the transcriptional down-regulation of Tie2 may be important for sustaining the activated endothelial phenotype during severe infections that progress to shock. Diminished flow is mechanosensed by ECs, resulting in flowdependent gene regulation (39) . Kurniati et al (13) showed that Tie2 is flow regulated in endotoxemia. Here, we tested several known Tie2 transcription factors according to their flow responsiveness. Although some of them were flow responsive, only GATA3 was suppressed in sepsis. Our interest in GATA3 was further stimulated by a report that GATA3 −/− mice display a heavily abnormal endothelial phenotype (40) . Future studies should also explore the mechanisms by which sepsis suppresses GATA3 expression. Nonetheless, our results suggest that GATA3 is important for normal expression of Tie2 when microvascular flow is intact, but that GATA3 alone cannot restore Tie2 expression to flow-associated levels in the absence of flow. One possibility is that GATA3 cooperates with other flow-responses transcriptional machinery to regulate Tie2 gene expression.
The kidney biopsies from deceased donors constitute an early pilot study to investigate Tie2 itself in human sepsis. Although tissue was only available at a very late stage of sepsis, the promising trends furnish motivation to study septic tissue from humans obtained across earlier time points that would more closely match the septic mouse tissue studied. More broadly, tissue-based investigation of the host response to sepsis could generate novel hypotheses about disease mechanisms.
If regulation of the Tie2 receptor itself-whether at the level of protein or mRNA-is so critical for the vascular phenotypic switch observed in sepsis, then why have ligandbased interventions met with success in experimental models (12)? First, it is possible that angiopoietins are acting through Tie2-independent alternate receptors such as integrins (41) . However, at least in the context of sepsis, studies from several laboratories propose the importance of Tie2 signaling per se downstream of angiopoietins (18, 42) . Second, ligand-based interventions-for example, excess angiopoietin-1, angiopoietin-2 siRNA, angiopoietin-2 neutralizing antibody, angiopoietin-2 clustering antibody (11, 18, 42, 43) -have enhanced survival in septic models, but not fully.
This raises the possibility that interventions to increase the available Tie2 protein for signaling AKT and downstream quiescence pathways could synergize with ligand-based interventions to increase the pool of phosphorylated Tie2 receptors. Conversely, the existence of several mechanisms to downregulate Tie2 suggests that mammals have evolved the ability to "finetune" Tie2 signaling both across time scales and in a quantitative fashion. Consistent with this notion of exquisite regulation are studies demonstrating how the phosphorylation of Tie2 can be modulated by heteromeric interactions with an paralog orphan receptor, Tie1 (36, 44) , and with a transmembrane tyrosine phosphatase enriched in the endothelium, vascular endothelial-protein tyrosine phosphatase (45) . Altogether, the present studies add significant new data regarding the multilayered mechanisms of Tie2 gene control in the context of severe infection and shock.
CONCLUSIONS
Down-regulation of Tie2 expression in sepsis may be a consequence of at least two distinct mechanisms. First, we found that TNF-α, a canonical inflammatory mediator of sepsis, triggered MMP14-dependent proteolytic cleavage of Tie2. Endothelial MMP14 was necessary and sufficient for Tie2 cleavage in ECs. Second, we found evidence that reduced microvascular flow-a common phenomenon as sepsis progress to shocksuppresses Tie2 transcription by down-regulating GATA3. Future studies are needed to investigate the mechanisms and therapeutic relevance of these findings.
